Saurolactam inhibits osteoclast differen
β
Myung Hee Kim; Shi Yong Ryu; Joon Sig Choi; Yong Ki Min; Seong Hwan Kim
π
Article
π
2009
π
John Wiley and Sons
π
English
β 610 KB
## Abstract The receptor activator of nuclear factorβΞΊB ligand (RANKL) plays a critical role in the differentiation and bone resorptive activity of osteoclasts. Recently, the development of antiβresorptive agents from natural substances has become a subject of interest. Therefore, we evaluated the